These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16814578)

  • 1. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T; Tubb J; Emery DW
    Blood Cells Mol Dis; 2006; 37(1):1-7. PubMed ID: 16814578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A; Dorazio R; Leboulch P
    Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo silencing of the human gamma-globin gene in murine erythroid cells following retroviral transduction.
    Lung HY; Meeus IS; Weinberg RS; Atweh GF
    Blood Cells Mol Dis; 2000 Dec; 26(6):613-9. PubMed ID: 11358353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.
    May C; Rivella S; Callegari J; Heller G; Gaensler KM; Luzzatto L; Sadelain M
    Nature; 2000 Jul; 406(6791):82-6. PubMed ID: 10894546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter.
    Sabatino DE; Seidel NE; Aviles-Mendoza GJ; Cline AP; Anderson SM; Gallagher PG; Bodine DM
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13294-9. PubMed ID: 11069298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G; Malik P
    Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of globin gene therapy for the treatment of beta-thalassaemia.
    Lisowski L; Sadelain M
    Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic globin gene delivery using lentiviral vectors.
    Rivella S; Sadelain M
    Curr Opin Mol Ther; 2002 Oct; 4(5):505-14. PubMed ID: 12435053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
    Morianos I; Siapati EK; Pongas G; Vassilopoulos G
    Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
    Oh IH; Fabry ME; Humphries RK; Pawliuk R; Leboulch P; Hoffman R; Nagel RL; Eaves C
    Exp Hematol; 2004 May; 32(5):461-9. PubMed ID: 15145214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
    Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
    Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin gene therapy for β-thalassemia.
    Bank A
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for the hemoglobin disorders.
    Persons DA; Nienhuis AW
    Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of sickle cell disease in transgenic mouse models by gene therapy.
    Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
    Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.